2025年全球组织诊断市场报告

近年来，组织诊断市场快速扩张，规模从2024年的57.7亿美元成长至2025年的63.8亿美元，复合年增长率达10.5%。预测期内的成长主要受人口老化、癌症疫情、技术进步、疾病认知度提升、病理工作流程效率提升等因素所驱动。

预计未来几年组织诊断市场将快速成长，到2029年将达到105.8亿美元，复合年增长率为13.5%。预测期内的成长归因于个人化医疗的发展、液态切片的兴起、人工智慧和机器学习的普及、远端病理学的扩展以及微创技术。预测期内的主要趋势包括数位病理学、人工智慧 (AI)、远端病理学服务、多重染色和成像以及基因组数据整合。

组织学是一种医疗程序，其中使用仪器取出组织，染色，然后送到实验室或病理学部门进行记录（组织学），用于患者护理，提供测量和描述，包括存在或不存在异常，以及根据适用法律对健康或疾病状态的解释（或诊断）。

组织诊断的主要产品类型包括耗材、抗体、试剂套件、试剂、探针、仪器、玻片染色系统、扫描器和组织处理系统。抗体用于检测感染疾病、识别过敏症以及在组织诊断中测量血液中的荷尔蒙和其他生物标记。组织诊断中使用的技术包括免疫组织化学 (IHC)、原位杂合反应(ISH)、数位病理学和工作流程管理以及用于检测乳癌、胃癌、淋巴瘤、前列腺癌和非小细胞肺癌 (NSCLC) 等疾病的特殊染色。组织诊断主要由医院、实验室、製药公司和合约研究组织使用。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供组织诊断市场统计数据，例如全球组织诊断行业市场规模、区域份额、竞争对手的市场份额、详细的组织诊断细分市场、市场趋势和商机，以及您在组织诊断行业取得成功所需的数据。本组织诊断市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

我们对该市场未来五年13.5%的成长率预测与先前保持不变。下降主要源自于美国与其他国家之间关税的影响。这将对美国造成直接影响，导致来自丹麦和瑞典等主要地区的免疫组织化学抗体和自动染色试剂供应链中断，这可能导致癌症检测延迟和病理检测成本增加。此外，由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，其影响也将更加广泛。

预计癌症发生率的上升将在未来几年推动组织诊断市场的成长。当基因改变导致细胞不受控制地生长，破坏身体组织并形成肿块（称为肿瘤）时，癌症就开始了。肿瘤可以是癌性的，也可以是良性的。各种因素，包括基因突变、致癌物质、吸烟、肥胖、辐射和激素，都可能导致癌症的发展。随着癌症患者数量的增加，对组织诊断等对于确定疾病进展至关重要的诊断技术的需求预计也会增加。例如，2024 年 2 月，总部位于瑞士的联合国机构世界卫生组织 (WHO) 预测，到 2050 年新增癌症病例数将超过 3,500 万，比 2022 年估计的 2,000 万增加 77%。因此，癌症发生率的上升正在刺激组织诊断市场的扩张。

预计不断增长的医疗支出将推动组织诊断市场的成长。医疗支出是指在特定期间内，国家或个人在医疗服务、治疗和产品上的总支出。这些支出支持先进诊断技术、研究和医疗基础设施（包括组织诊断）的开发、普及和利用。例如，美国非营利组织美国医学会 ( 美国 Medical Association) 在 2024 年 7 月报告称，从 2012 年到 2022 年，处方药的复合年增长率将达到 4.7%，达到最高水平，而医院护理和医生服务的复合年增长率分别为 4.4% 和 4.2%。医疗支出的成长将推动诊断技术的进步，进一步刺激组织诊断市场的成长。

产品类型创新是组织诊断市场的一个发展趋势，各公司推出的先进产品和解决方案能够收集多种样本类型、同时检测多个样本、实现实验室程序自动化以及使诊断更容易获得。竞争对手正专注于开发自动化组织诊断系统，以获得竞争优势并增加收益。例如，2022 年 6 月，瑞士医疗保健公司罗氏推出了用于癌症诊断的 BenchMark ULTRA PLUS 系统。该组织染色系统具有优化的工作流程、提高的检测效率和永续的环境特性，使病理学家能够为医生和患者提供高品质、及时的结果。该系统的关键创新包括直觉的软体、远端监控功能、用于改善用户体验的整合触控萤幕以及永续的废弃物管理和包装。

技术进步，尤其是人工智慧 (AI) 的整合，正在影响组织诊断市场。 AI 正被用于分析医学影像和病理数据，从而提高疾病检测和分类的准确性和效率。例如，Qritive 于 2023 年推出了 Qai Prostate，这是一款基于 AI 的前列腺癌检测工具，为病理学家提供了先进的功能，能够检测和分类切片检查组织样本中恶性和良性肿瘤的位置。此次 AI 的融合是组织诊断市场提高癌症诊断和治疗准确性的策略性倡议。

2022年2月的亮点是Labcorp以5.75亿美元收购了Personal Genome Diagnostics (PGDx)。此次收购增强了Labcorp基于次世代定序的基因组分析能力，并增强了其现有的液态切片能力，体现了业界对癌症基因组学进步的决心。

参与组织诊断市场的主要企业包括 F. Hoffmann-La Roche Ltd.、Danaher Corporation、Thermo Fisher Scientific Inc.、Abbott Laboratories、Agilent Technologies Inc.、Merck KGaA、BioGenex Laboratories、Sakura Finetek Co.、Philips Healthcare NV、Bio-Rad Laboratories、Hoanax Corporation、Cell Signaling Technology Inc.、Enzo Life Sciences Inc.、Epitomics Inc.、Fluidigm Corporation、GE Healthcare Technologies Inc.、Genomic Health Inc.、Illumina Health Inc.、Agilent Technologies Inc.、Merck KGaA、BioGenex Laboratories、 Sakura Finetek Co.、Genomic Health系统Srl、Myriad Genetics Inc.、NanoString Technologies Inc.、PerkinElmer Inc.、QIAGEN NV、Siemens Healthineers AG、蔡司集团、CytomX Therapeutics Inc.

2024 年，北美是组织诊断市场最大的地区。全球组织诊断市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

组织诊断市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

组织诊断市场涵盖营业单位从耗材和仪器中获得的收益。市场价值包括服务供应商销售或包含在服务产品中的相关商品的价值。仅包括营业单位之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球组织评估：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球组织诊断市场：成长率分析
• 全球组织诊断市场表现：规模与成长，2019-2024
• 全球组织诊断市场预测：规模与成长，2024-2029年，2034年
• 全球组织评估：总目标市场（TAM）

第六章 市场细分

• 全球组织诊断市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 耗材
• 抗体
• 套件
• 试剂
• 探测
• 装置
• 玻片染色系统
• 扫描器
• 组织处理系统
• 全球组织诊断市场：依技术、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 免疫组织化学（IHC）
• 原位杂交（ISH）
• 数位病理学和工作流程管理
• 特殊染色
• 全球组织诊断市场：依疾病、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 乳癌
• 胃癌
• 淋巴瘤
• 摄护腺癌
• 非小细胞肺癌（NSCLC）
• 全球组织诊断市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
• 医院
• 研究办公室
• 製药公司
• 合约研究组织
• 全球组织诊断市场：按耗材细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 切片穿刺针
• 玻片和盖玻片
• 组织包埋材料
• 全球组织诊断市场：按抗体类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
• 一抗
• 二抗
• 单株抗体
• 多株抗体
• 全球组织诊断市场：依试剂盒类型套件，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 诊断试剂套件
• 检测试剂套件
• 染色试剂套件
• 全球组织诊断市场：按试剂类型、效能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 稳定剂
• 染色试剂
• 抗原活化溶液
• 全球组织诊断市场：按探针细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 萤光探针
• 分子探针
• 杂合反应探针
• 全球组织诊断市场：依设备类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 显微镜
• 组织微阵列仪
• 雷射捕获晶粒仪
• 全球组织诊断市场：玻片染色系统细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 自动染色设备
• 手动染色系统
• 全球组织诊断市场：按扫描器类型、效能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 数位幻灯片扫描仪
• 全幻灯片成像系统
• 全球组织诊断市场：依组织处理系统细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 组织处理装置
• 嵌入式中心
• 切片机

第七章 区域和国家分析

• 全球组织诊断市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球组织诊断市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 组织诊断市场：竞争格局
• 组织诊断市场：公司简介
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Merck KGaA
• BioGenex Laboratories
• Sakura Finetek Co. Ltd.
• Philips Healthcare NV
• Bio-Rad Laboratories
• Ventana Medical Systems Inc.
• Hologic Inc.
• Becton Dickinson and Company
• Sysmex Corporation
• Cell Signaling Technology Inc.
• Enzo Life Sciences Inc.
• Epitomics Inc.
• Fluidigm Corporation
• GE Healthcare Technologies Inc.
• Genomic Health Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

• 2029年组织诊断市场：提供新机会的国家
• 2029年组织诊断市场：细分市场带来新机会
• 2029年组织诊断市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章 附录

Tissue diagnostic refers to a medical procedure that uses instruments to remove and stain tissue that must be sent to a laboratory or pathology department for documentation of what was excised for patient care (for tissue diagnostics). This offers measurements and descriptions, including any abnormalities, and an interpretation (or diagnosis) of health or disease status, under applicable legislation.

The main types of products in tissue diagnostic are consumables, antibodies, kits, reagents, probes, instrument, slide staining system, scanner and tissue processing system. The antibodies are used for the detection of infections, recognition of allergies, and the measurement of hormones and other biological markers in the blood in tissue diagnostics. The technologies used in tissue diagnostic are immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and workflow management and special staining to detect diseases such as breast cancer, gastric cancer, lymphoma, prostate cancer and non-small cell lung cancer (NSCLC). Tissue diagnostic is mostly used in hospitals, research laboratories, pharmaceutical companies, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tissue diagnostic market research report is one of a series of new reports from The Business Research Company that provides tissue diagnostic market statistics, including tissue diagnostic industry global market size, regional shares, competitors with a tissue diagnostic market share, detailed tissue diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the tissue diagnostic industry. This tissue diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue diagnostic market size has grown rapidly in recent years. It will grow from $5.77 billion in 2024 to $6.38 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to aging population, cancer prevalence, technological advancements, increased disease awareness, pathology workflow efficiency.

The tissue diagnostic market size is expected to see rapid growth in the next few years. It will grow to $10.58 billion in 2029 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to personalized medicine growth, rise of liquid biopsies, ai and machine learning adoption, telepathology expansion, minimally invasive techniques. Major trends in the forecast period include digital pathology, artificial intelligence (ai), telepathology services, multiplex staining and imaging, integration of genomic data.

The forecast of 13.5% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for immunohistochemistry antibodies and automated staining reagents, sourced from key regions such as Denmark and Sweden, could lead to delays in cancer detection and increased pathology costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of cancer is expected to drive the growth of the tissue diagnostic market in the coming years. Cancer begins when genetic changes cause cells to grow uncontrollably, destroying body tissue and forming a mass known as a tumor, which can be either cancerous or benign. Various factors, including genetic mutations, carcinogens, smoking, obesity, radiation, and hormones, can lead to the development of cancer. As cancer cases rise, the demand for diagnostic procedures like tissue diagnostics will grow, as these are essential in determining the disease's progression. For example, in February 2024, the World Health Organization, a Switzerland-based United Nations agency, projected that new cancer cases would rise to over 35 million by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the rising cancer incidence is fueling the expansion of the tissue diagnostic market.

The increasing healthcare expenditure is expected to drive the growth of the tissue diagnostic market. Healthcare expenditure refers to the total amount of money spent on healthcare services, treatments, and products over a certain period, either at the national or individual level. This spending supports the development, accessibility, and utilization of advanced diagnostic technologies, research, and medical infrastructure, including tissue diagnostics. For example, in July 2024, the American Medical Association, a US-based nonprofit organization, reported that from 2012 to 2022, the average annual growth rate for prescription drugs was the highest at 4.7%, compared to 4.4% for hospital care and 4.2% for physician services. This increase in healthcare spending helps foster advancements in diagnostic technologies, driving the growth of the tissue diagnostic market.

Product innovation is a growing trend in the tissue diagnostic market, with companies introducing advanced products and solutions that can collect multiple sample types, test multiple samples simultaneously, automate lab operations, and make diagnostics more accessible. Leading players are focusing on developing automated tissue diagnostic systems to gain a competitive advantage and boost revenue. For instance, in June 2022, Roche, a Switzerland-based healthcare company, launched the BenchMark ULTRA PLUS system for cancer diagnostics. This tissue staining system features optimized workflow, enhanced testing efficiency, and sustainable environmental features, allowing pathologists to deliver high-quality, timely results to doctors and patients. Key innovations in the system include intuitive software, remote monitoring capabilities, an integrated touchscreen for a better user experience, and environmentally sustainable waste management and packaging.

The technological advancements, particularly the integration of artificial intelligence (AI), are influencing the tissue diagnostic market. AI is employed to analyze medical images and pathological data, enhancing the accuracy and efficiency of disease detection and classification. For instance, in 2023, Qritive introduced the Qai Prostate, an AI-powered prostate cancer detection tool, providing pathologists with advanced capabilities for detecting and classifying malignant and benign tumor locations in biopsy tissue samples. This integration of AI represents a strategic move to improve precision in cancer diagnosis and treatment within the tissue diagnostic market.

In February 2022, Labcorp's acquisition of Personal Genome Diagnostics (PGDx) for $575 million stands out. This move strengthens Labcorp's next-generation sequencing-based genomic profiling capabilities and enhances existing liquid biopsy capabilities, reflecting the industry's commitment to advancing cancer genomics.

Major companies operating in the tissue diagnostic market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Merck KGaA, BioGenex Laboratories, Sakura Finetek Co. Ltd., Philips Healthcare NV, Bio-Rad Laboratories, Ventana Medical Systems Inc., Hologic Inc., Becton Dickinson and Company, Sysmex Corporation, Cell Signaling Technology Inc., Enzo Life Sciences Inc., Epitomics Inc., Fluidigm Corporation, GE Healthcare Technologies Inc., Genomic Health Inc., Illumina Inc., Leica Microsystems GmbH, Menarini Diagnostics S.r.l, Myriad Genetics Inc., NanoString Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Zeiss Group AG, CytomX Therapeutics Inc.

North America was the largest region in the tissue diagnostic market in 2024. The regions covered in the global tissue diagnostic industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the tissue diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The tissue diagnostic market includes revenues earned by entities by consumables and instruments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Consumables; Antibodies; Kits; Reagents; Probes; Instruments; Slide Staining System; Scanner; Tissue Processing system
• 2) By Technology: Immunohistochemistry (IHC); In Situ Hybridization (ISH); Digital Pathology And Workflow Management; Special Staining
• 3) By Disease: Breast Cancer; Gastric Cancer; Lymphoma; Prostate Cancer; Non-Small Cell Lung Cancer (NSCLC)
• 4) By End User: Hospitals; Research Laboratories; Pharmaceutical Companies; Contract Research Organizations
• Subsegments:
• 1) By Consumables: Biopsy Needles; Slides And Cover Slips; Tissue Embedding Materials
• 2) By Antibodies: Primary Antibodies; Secondary Antibodies; Monoclonal Antibodies; Polyclonal Antibodies
• 3) By Kits: Diagnostic Kits; Assay Kits; Staining Kits
• 4) By Reagents: Fixatives; Staining Reagents; Antigen Retrieval Solutions
• 5) By Probes: Fluorescent Probes; Molecular Probes; Hybridization Probes
• 6) By Instruments: Microscopes; Tissue Microarray Instruments; Laser Capture Microdissection Instruments
• 7) By Slide Staining System: Automated Stainers; Manual Staining Systems
• 8) By Scanner: Digital Slide Scanners; Whole Slide Imaging Systems
• 9) By Tissue Processing System: Tissue Processors; Embedding Centers; Microtomes
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Danaher Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Agilent Technologies Inc.; Merck KGaA; BioGenex Laboratories; Sakura Finetek Co. Ltd.; Philips Healthcare NV; Bio-Rad Laboratories; Ventana Medical Systems Inc.; Hologic Inc.; Becton Dickinson and Company; Sysmex Corporation; Cell Signaling Technology Inc.; Enzo Life Sciences Inc.; Epitomics Inc.; Fluidigm Corporation; GE Healthcare Technologies Inc.; Genomic Health Inc.; Illumina Inc.; Leica Microsystems GmbH; Menarini Diagnostics S.r.l; Myriad Genetics Inc.; NanoString Technologies Inc.; PerkinElmer Inc.; QIAGEN N.V.; Siemens Healthineers AG; Zeiss Group AG; CytomX Therapeutics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Diagnostic Market Characteristics

3. Tissue Diagnostic Market Trends And Strategies

4. Tissue Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tissue Diagnostic Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tissue Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tissue Diagnostic Market Growth Rate Analysis
• 5.4. Global Tissue Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tissue Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tissue Diagnostic Total Addressable Market (TAM)

6. Tissue Diagnostic Market Segmentation

• 6.1. Global Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Antibodies
• Kits
• Reagents
• Probes
• Instruments
• Slide Staining System
• Scanner
• Tissue Processing system
• 6.2. Global Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunohistochemistry (IHC)
• In Situ Hybridization (ISH)
• Digital Pathology And Workflow Management
• Special Staining
• 6.3. Global Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Gastric Cancer
• Lymphoma
• Prostate Cancer
• Non-Small Cell Lung Cancer (NSCLC)
• 6.4. Global Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Laboratories
• Pharmaceutical Companies
• Contract Research Organizations
• 6.5. Global Tissue Diagnostic Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopsy Needles
• Slides And Cover Slips
• Tissue Embedding Materials
• 6.6. Global Tissue Diagnostic Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Antibodies
• Secondary Antibodies
• Monoclonal Antibodies
• Polyclonal Antibodies
• 6.7. Global Tissue Diagnostic Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Kits
• Assay Kits
• Staining Kits
• 6.8. Global Tissue Diagnostic Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fixatives
• Staining Reagents
• Antigen Retrieval Solutions
• 6.9. Global Tissue Diagnostic Market, Sub-Segmentation Of Probes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluorescent Probes
• Molecular Probes
• Hybridization Probes
• 6.10. Global Tissue Diagnostic Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microscopes
• Tissue Microarray Instruments
• Laser Capture Microdissection Instruments
• 6.11. Global Tissue Diagnostic Market, Sub-Segmentation Of Slide Staining System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Stainers
• Manual Staining Systems
• 6.12. Global Tissue Diagnostic Market, Sub-Segmentation Of Scanner, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Digital Slide Scanners
• Whole Slide Imaging Systems
• 6.13. Global Tissue Diagnostic Market, Sub-Segmentation Of Tissue Processing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tissue Processors
• Embedding Centers
• Microtomes

7. Tissue Diagnostic Market Regional And Country Analysis

• 7.1. Global Tissue Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tissue Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Diagnostic Market

• 8.1. Asia-Pacific Tissue Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Diagnostic Market

• 9.1. China Tissue Diagnostic Market Overview
• 9.2. China Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Diagnostic Market

• 10.1. India Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Diagnostic Market

• 11.1. Japan Tissue Diagnostic Market Overview
• 11.2. Japan Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Diagnostic Market

• 12.1. Australia Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Diagnostic Market

• 13.1. Indonesia Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Diagnostic Market

• 14.1. South Korea Tissue Diagnostic Market Overview
• 14.2. South Korea Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Diagnostic Market

• 15.1. Western Europe Tissue Diagnostic Market Overview
• 15.2. Western Europe Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Diagnostic Market

• 16.1. UK Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Diagnostic Market

• 17.1. Germany Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Diagnostic Market

• 18.1. France Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Diagnostic Market

• 19.1. Italy Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Diagnostic Market

• 20.1. Spain Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Diagnostic Market

• 21.1. Eastern Europe Tissue Diagnostic Market Overview
• 21.2. Eastern Europe Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Diagnostic Market

• 22.1. Russia Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Diagnostic Market

• 23.1. North America Tissue Diagnostic Market Overview
• 23.2. North America Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Diagnostic Market

• 24.1. USA Tissue Diagnostic Market Overview
• 24.2. USA Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Diagnostic Market

• 25.1. Canada Tissue Diagnostic Market Overview
• 25.2. Canada Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Diagnostic Market

• 26.1. South America Tissue Diagnostic Market Overview
• 26.2. South America Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Diagnostic Market

• 27.1. Brazil Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Diagnostic Market

• 28.1. Middle East Tissue Diagnostic Market Overview
• 28.2. Middle East Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Diagnostic Market

• 29.1. Africa Tissue Diagnostic Market Overview
• 29.2. Africa Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Diagnostic Market Competitive Landscape And Company Profiles

• 30.1. Tissue Diagnostic Market Competitive Landscape
• 30.2. Tissue Diagnostic Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Diagnostic Market Other Major And Innovative Companies

• 31.1. Merck KGaA
• 31.2. BioGenex Laboratories
• 31.3. Sakura Finetek Co. Ltd.
• 31.4. Philips Healthcare NV
• 31.5. Bio-Rad Laboratories
• 31.6. Ventana Medical Systems Inc.
• 31.7. Hologic Inc.
• 31.8. Becton Dickinson and Company
• 31.9. Sysmex Corporation
• 31.10. Cell Signaling Technology Inc.
• 31.11. Enzo Life Sciences Inc.
• 31.12. Epitomics Inc.
• 31.13. Fluidigm Corporation
• 31.14. GE Healthcare Technologies Inc.
• 31.15. Genomic Health Inc.

32. Global Tissue Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Diagnostic Market

34. Recent Developments In The Tissue Diagnostic Market

35. Tissue Diagnostic Market High Potential Countries, Segments and Strategies

• 35.1 Tissue Diagnostic Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tissue Diagnostic Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tissue Diagnostic Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer